Health Care · Euronext Paris · FYE 12-31 · Prices AT CLOSE 2026-07-29 (EUR) — end-of-day, never a live or intraday quote
Last €34.40Day +0.29%Mkt cap $592MP/E (FY) 14.4×1Y −28.6%Off 52W high −35.9%Vol (1Y) 34.9%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 4,183 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Fair value (model)€38.99 |
| Implied upside+13.7% |
| Valuation confidenceHIGH |
| Price impliesUNDEMANDING · 5.8% growth |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run.
| P/E (FY)14.4× |
| Sales (TTM)€216.8M |
| Earnings (TTM)€36.2M |
| ROE16.1% |
| Net margin16.7% |
| Debt / equity0.08× |
| Total debt / EBITDA0.32× |
| EPS growth 3Y−2.5% |
| Sales growth 3Y3.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−20.3% |
| 1Y−28.6% |
| 3Y−55.7% |
| 5Y−60.0% |
| 10Y+51.2% |
| Since incept. (ann.)+11.6% |
Total return through 2026-07-29 · series begins 2010-01-04. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)34.9% |
| Ann. volatility (3Y)38.9% |
| Sharpe (1Y)−0.77 |
| Sharpe (3Y)−0.54 |
| Max drawdown (1Y)−36.6% |
| Max drawdown (3Y)−59.8% |
| Beta (3Y vs SPY)−0.33 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for EQS.PA.
No reported quarters on file for EQS.PA.
